AZD-26 is an allosteric AKT inhibitor (IC50: 1.04 μM).

Loganic acid and geniposide exhibit both sides effect on superoxide generation.

2′,2′-Difluorodeoxyuridine (dFdU), the major metabolite of Gemcitabine, exhibits anticancer and antitumor activities, shows radiosensitization under hypoxic conditions, and can be used to study pancreatic cancer.